SPL 2.11% 9.3¢ starpharma holdings limited

I expect little in the quarterly that is not already known. What...

  1. 587 Posts.
    lightbulb Created with Sketch. 79
    I expect little in the quarterly that is not already known. What I hope for is a separate market sensitive update on vivagel and or the dep doc trials.

    Quarterly will be filled with fluff and unreliable forecasts like previous.

    Note I remain a strong buy on SPL, but expect little of the quarterly.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.